Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for atrial fibrillation and incidence of sudden cardiac death during long-term follow-up in hospitalized COVID-19 survivors
Fiedler, Lukas,
Motloch, Lukas J.,
Dieplinger, Anna-Maria,
Jirak, Peter,
Davtyan, Paruir,
Gareeva, Diana,
Badykova, Elena,
Badykov, Marat,
Lakman, Irina,
Agapitov, Aleksandr,
Sadikova, Liana,
Pavlov, Valentin,
Föttinger, Fabian,
Mirna, Moritz,
Kopp, Kristen,
Hoppe, Uta C.,
Pistulli, Rudin,
Cai, Benzhi,
Yang, Baofeng,
Zagidullin, Naufal
Связанные документы (рекомендация CORE)